NYSE:CVS - CVS Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $117.47
  • Forecasted Upside: 11.78 %
  • Number of Analysts: 20
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 16 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.04 (1.00%)

This chart shows the closing price for CVS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CVS Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CVS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVS

Analyst Price Target is $117.47
▲ +11.78% Upside Potential
This price target is based on 20 analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $117.47, with a high forecast of $127.00 and a low forecast of $107.00. The average price target represents a 11.78% upside from the last price of $105.09.

This chart shows the closing price for CVS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 20 polled investment analysts is to buy stock in CVS Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/8/2022Credit Suisse GroupBoost Price TargetOutperform$113.00 ➝ $117.00Low
8/4/2022UBS GroupBoost Price TargetBuy$118.00 ➝ $127.00Low
8/4/2022Deutsche Bank AktiengesellschaftBoost Price Target$113.00 ➝ $120.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$120.00Medium
5/26/2022Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$122.00 ➝ $112.00Medium
5/5/2022Deutsche Bank AktiengesellschaftBoost Price Target$110.00 ➝ $113.00High
4/7/2022Tigress FinancialBoost Price Target$122.00 ➝ $125.00Low
3/29/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$110.00High
2/17/2022Deutsche Bank AktiengesellschaftBoost Price Target$107.00 ➝ $110.00Medium
2/11/2022Raymond JamesDowngradeStrong-Buy ➝ Outperform$115.00 ➝ $120.00High
2/10/2022BMO Capital MarketsBoost Price Target$108.00 ➝ $120.00Medium
1/12/2022Robert W. BairdBoost Price Target$107.00 ➝ $110.00Low
1/11/2022Sanford C. BernsteinBoost Price Target$111.00 ➝ $116.00Low
1/10/2022Edward JonesUpgradeHold ➝ BuyMedium
1/5/2022Truist FinancialBoost Price TargetBuy ➝ Buy$118.00 ➝ $124.00Low
12/23/2021Tigress FinancialBoost Price TargetBuy$108.00 ➝ $122.00Low
12/20/2021MizuhoBoost Price TargetBuy$110.00 ➝ $115.00Low
12/14/2021Robert W. BairdReiterated RatingHoldLow
12/14/2021The Goldman Sachs GroupInitiated CoverageBuy$121.00Low
12/13/2021Morgan StanleyBoost Price TargetOverweight ➝ Overweight$115.00 ➝ $125.00Low
12/13/2021Wells Fargo & CompanyBoost Price TargetEqual Weight ➝ Equal Weight$98.00 ➝ $107.00Low
12/13/2021Robert W. BairdBoost Price TargetNeutral ➝ Neutral$100.00 ➝ $107.00Low
12/10/2021Truist FinancialBoost Price TargetBuy ➝ Buy$112.00 ➝ $118.00Low
12/10/2021CowenBoost Price TargetOutperform ➝ Outperform$103.00 ➝ $114.00Low
12/10/2021Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$107.00 ➝ $119.00Medium
12/10/2021Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$107.00 ➝ $120.00Medium
12/10/2021MizuhoBoost Price TargetBuy ➝ Buy$105.00 ➝ $110.00Medium
12/6/2021Morgan StanleyBoost Price TargetOverweight$114.00 ➝ $115.00Medium
12/1/2021Seaport Res PtnReiterated RatingBuyMedium
11/10/2021MizuhoBoost Price TargetBuy$98.00 ➝ $105.00Low
11/5/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$101.00 ➝ $107.00Medium
11/5/2021Credit Suisse GroupBoost Price TargetOutperform$100.00 ➝ $107.00Low
11/5/2021JPMorgan Chase & Co.Boost Price TargetBuy ➝ Overweight$107.00 ➝ $115.00Low
11/4/2021Truist FinancialBoost Price TargetBuy$94.00 ➝ $112.00Medium
11/4/2021Royal Bank of CanadaBoost Price TargetOutperform$97.00 ➝ $107.00Medium
11/4/2021Raymond JamesBoost Price TargetStrong-Buy$95.00 ➝ $115.00Medium
11/4/2021CitigroupBoost Price TargetBuy$98.00 ➝ $111.00Medium
11/4/2021BarclaysBoost Price TargetOverweight$100.00 ➝ $110.00Medium
10/21/2021MizuhoReiterated RatingBuyMedium
8/31/2021Morgan StanleyBoost Price TargetTop Pick ➝ Overweight$99.00 ➝ $114.00High
8/5/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$95.00 ➝ $101.00High
7/23/2021Tigress FinancialReiterated RatingBuy$108.00Low
6/22/2021Deutsche Bank AktiengesellschaftLower Price TargetBuy$99.00 ➝ $95.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$89.00N/A
5/19/2021BMO Capital MarketsBoost Price TargetPositive ➝ Market Perform$90.00 ➝ $96.00High
5/19/2021BarclaysBoost Price TargetOverweight$92.00 ➝ $100.00High
5/19/2021Wolfe ResearchBoost Price TargetPositive ➝ Outperform$82.00 ➝ $93.00High
5/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$89.00Medium
5/12/2021MizuhoBoost Price TargetPositive ➝ Buy$82.00 ➝ $98.00Low
5/6/2021Credit Suisse GroupBoost Price TargetOutperform$91.00 ➝ $100.00Low
5/6/2021BMO Capital MarketsBoost Price TargetMarket Perform$82.00 ➝ $90.00Low
5/5/2021CitigroupBoost Price Target$83.00 ➝ $98.00Medium
5/5/2021Jefferies Financial GroupBoost Price TargetBuy$90.00 ➝ $95.00Medium
5/5/2021Raymond JamesBoost Price TargetStrong-Buy$90.00 ➝ $95.00High
5/5/2021Royal Bank of CanadaBoost Price TargetOutperform$80.00 ➝ $91.00High
4/14/2021Truist FinancialBoost Price TargetBuy$80.00 ➝ $88.00Low
4/14/2021Morgan StanleyBoost Price TargetOverweight$86.00 ➝ $92.00Medium
3/23/2021GuggenheimReiterated RatingBuy ➝ NeutralMedium
3/17/2021GuggenheimDowngradeBuy ➝ NeutralLow
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$90.00Low
12/14/2020SVB LeerinkBoost Price TargetMarket Perform$73.00 ➝ $80.00High
11/11/2020Piper SandlerBoost Price TargetOverweight$72.00 ➝ $76.00Low
11/9/2020Cantor FitzgeraldReiterated RatingOverweightHigh
11/9/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$104.00 ➝ $101.00High
9/17/2020Piper SandlerInitiated CoverageOverweight$72.00 ➝ $72.00Medium
8/7/2020Credit Suisse GroupBoost Price TargetOutperform$75.00 ➝ $90.00Medium
8/6/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$109.00 ➝ $104.00Low
8/6/2020SVB LeerinkBoost Price TargetMarket Perform$72.00 ➝ $73.00Low
7/9/2020Royal Bank of CanadaReiterated RatingBuyLow
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$72.00Low
5/14/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform$75.00Low
5/8/2020Credit Suisse GroupReiterated RatingHoldLow
5/7/2020Robert W. BairdBoost Price TargetNeutral$62.00 ➝ $66.00Low
5/7/2020UBS GroupLower Price TargetBuy$85.00 ➝ $79.00Low
5/7/2020CitigroupLower Price TargetBuy$86.00 ➝ $75.00Low
5/7/2020Morgan StanleyBoost Price TargetOverweight$71.00 ➝ $77.00Low
5/6/2020Royal Bank of CanadaReiterated RatingBuy$77.00High
5/6/2020OppenheimerReiterated RatingHoldHigh
5/4/2020JPMorgan Chase & Co.Lower Price TargetOverweight$97.00 ➝ $94.00Low
4/24/2020Tigress FinancialReiterated RatingBuyMedium
4/13/2020Morgan StanleyBoost Price TargetOverweight$70.00 ➝ $71.00Low
4/13/2020SunTrust BanksLower Price TargetBuy$90.00 ➝ $80.00Medium
4/12/2020Royal Bank of CanadaReiterated RatingBuy$77.00High
3/27/2020Morgan StanleyLower Price TargetOverweight$88.00 ➝ $70.00Medium
3/27/2020Robert W. BairdLower Price TargetNeutral$73.00 ➝ $62.00Medium
3/25/2020Royal Bank of CanadaLower Price Target$85.00 ➝ $81.00Medium
3/19/2020Credit Suisse GroupReiterated RatingHold$75.00Medium
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$97.00 ➝ $109.00Low
2/14/2020CitigroupBoost Price TargetBuy$83.00 ➝ $86.00Medium
2/13/2020Robert W. BairdBoost Price TargetNeutral$70.00 ➝ $73.00Medium
2/13/2020UBS GroupBoost Price TargetBuy$78.00 ➝ $85.00Medium
2/13/2020Cantor FitzgeraldBoost Price TargetOverweight$85.00 ➝ $90.00Medium
2/12/2020OppenheimerInitiated CoverageHoldMedium
2/12/2020CfraBoost Price TargetStrong-Buy$85.00 ➝ $86.00Medium
12/19/2019JPMorgan Chase & Co.Boost Price TargetOverweight$88.00 ➝ $97.00Low
12/4/2019Raymond JamesReiterated RatingStrong-Buy$80.00 ➝ $90.00Low
11/8/2019MizuhoBoost Price TargetBuy$71.00 ➝ $82.00Low
11/7/2019UBS GroupReiterated RatingBuy$78.00 ➝ $78.00Low
11/7/2019Raymond JamesBoost Price TargetStrong-Buy$75.00 ➝ $80.00Low
11/7/2019SunTrust BanksBoost Price TargetBuy$85.00Low
11/7/2019CitigroupBoost Price TargetBuy$72.00 ➝ $83.00Low
10/21/2019CowenSet Price TargetBuy$76.00Low
9/27/2019Royal Bank of CanadaInitiated CoverageOutperform$85.00Low
9/26/2019Morgan StanleyBoost Price TargetOverweight$74.00 ➝ $77.00Medium
9/12/2019Bank of AmericaBoost Price TargetBuy$72.00 ➝ $75.00Low
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$91.00Medium
8/27/2019CowenReiterated RatingOutperform$69.00 ➝ $76.00Medium
8/11/2019Morgan StanleyReiterated RatingBuy$74.00Low
8/8/2019CitigroupBoost Price TargetBuy$68.00 ➝ $72.00Medium
8/7/2019Evercore ISISet Price TargetBuy$63.00Low
6/5/2019MizuhoSet Price TargetBuy$71.00Medium
6/5/2019Standpoint ResearchUpgradeHold ➝ BuyHigh
5/3/2019BMO Capital MarketsSet Price TargetHold$63.00Low
5/2/2019CitigroupSet Price TargetBuy$74.00Low
5/2/2019UBS GroupLower Price TargetSell ➝ Sell$74.00 ➝ $67.00Low
5/1/2019Cantor FitzgeraldReiterated RatingBuy$80.00Low
4/29/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$92.00 ➝ $74.00Low
4/29/2019Credit Suisse GroupDowngradeOutperform ➝ Neutral$73.00 ➝ $61.00Medium
4/21/2019Cantor FitzgeraldReiterated RatingBuy$80.00Low
4/18/2019Raymond JamesLower Price TargetStrong-Buy ➝ Strong-Buy$90.00 ➝ $75.00Low
4/18/2019GuggenheimInitiated CoverageBuy ➝ Buy$90.00 ➝ $75.00Low
4/15/2019CIBCReiterated RatingOutperform ➝ Market PerformLow
4/15/2019OppenheimerDowngradeOutperform ➝ Market PerformLow
4/11/2019BarclaysSet Price TargetBuy$73.00High
4/10/2019BMO Capital MarketsInitiated CoverageOutperform$58.00Medium
4/10/2019SunTrust BanksLower Price Target$85.00 ➝ $65.00Low
4/10/2019Bank of AmericaReiterated RatingBuy$82.00 ➝ $74.00Low
3/12/2019Sanford C. BernsteinInitiated CoverageOutperform ➝ Outperform$76.00High
3/6/2019CitigroupLower Price TargetBuy ➝ Buy$94.00 ➝ $68.00Medium
2/25/2019ArgusLower Price TargetBuy ➝ Positive$100.00 ➝ $80.00Low
2/22/2019Morgan StanleySet Price TargetBuy$92.00Low
2/21/2019SunTrust BanksLower Price TargetBuy$85.00Medium
2/21/2019UBS GroupLower Price TargetBuy ➝ Buy$75.00 ➝ $74.00High
2/21/2019Loop CapitalLower Price TargetIn-Line ➝ Hold$68.00High
2/21/2019JPMorgan Chase & Co.Reiterated RatingOverweight$91.00High
2/21/2019Cantor FitzgeraldReiterated RatingOverweight$80.00High
2/20/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$104.00 ➝ $68.00High
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$75.00Low
1/3/2019Cantor FitzgeraldReiterated RatingBuy$96.00Low
1/3/2019Bank of AmericaReiterated RatingBuy$92.00Low
12/18/2018BarclaysInitiated CoverageOverweight ➝ Overweight$91.00Medium
12/11/2018SVB LeerinkInitiated CoverageOutperformMedium
12/2/2018Cantor FitzgeraldInitiated CoverageOverweight$96.00 ➝ $77.84Low
11/29/2018The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$87.00Low
11/28/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$89.00Low
11/28/2018Loop CapitalSet Price TargetHold$80.00High
11/27/2018Wells Fargo & CompanyBoost Price TargetOutperform$98.00 ➝ $104.00Medium
11/26/2018Cantor FitzgeraldInitiated CoverageOverweight$96.00High
11/13/2018ArgusBoost Price TargetBuy$100.00Low
11/9/2018Loop CapitalSet Price TargetHold$70.00 ➝ $80.00N/A
11/8/2018SVB LeerinkBoost Price TargetOutperform ➝ Positive$85.00 ➝ $95.00Medium
11/7/2018Morgan StanleySet Price TargetBuy$80.00 ➝ $100.00Low
11/7/2018Royal Bank of CanadaSet Price TargetBuy$100.00Medium
10/26/2018Tigress FinancialReiterated RatingBuyLow
10/25/2018Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
10/23/2018Royal Bank of CanadaSet Price TargetBuy$99.00Low
9/18/2018Royal Bank of CanadaBoost Price TargetOutperform$101.00Medium
9/17/2018Bank of AmericaBoost Price TargetBuy$86.00 ➝ $90.00Medium
8/9/2018SVB LeerinkSet Price TargetOutperform$85.00 ➝ $80.00Low
8/8/2018Royal Bank of CanadaReiterated RatingPositive ➝ Buy$90.00Low
7/9/2018CitigroupReiterated RatingNeutral ➝ Buy$81.00Low
7/3/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$88.00 ➝ $80.00Low
6/30/2018MizuhoReiterated RatingBuyLow
6/29/2018Royal Bank of CanadaLower Price TargetOutperform$84.00Medium
6/13/2018MizuhoSet Price TargetBuy$95.00High
5/7/2018Loop CapitalSet Price TargetHold$68.00Medium
4/11/2018Bank of AmericaLower Price TargetBuy ➝ Buy$91.00 ➝ $88.00Low
4/10/2018SVB LeerinkSet Price TargetBuy$85.00Low
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$91.00Low
2/13/2018CitigroupSet Price TargetNeutral ➝ Neutral$80.00 ➝ $77.00Low
2/9/2018SVB LeerinkSet Price TargetOutperform ➝ Buy$90.00 ➝ $85.00Low
2/9/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$85.00 ➝ $80.00Low
2/9/2018Needham & Company LLCSet Price TargetStrong-Buy ➝ Buy$100.00 ➝ $98.00Medium
2/8/2018Royal Bank of CanadaSet Price TargetBuy$89.00Medium
1/30/2018Needham & Company LLCUpgradeBuy ➝ Strong-Buy$88.00 ➝ $100.00High
1/24/2018MizuhoSet Price TargetBuy$95.00Low
1/18/2018CowenReiterated RatingOutperform$81.00 ➝ $99.00Low
1/8/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$82.00 ➝ $90.00Low
1/5/2018SunTrust BanksBoost Price TargetBuy$90.00High
1/5/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$88.00High
1/4/2018Raymond JamesUpgradeOutperform ➝ Strong-Buy$90.00High
1/4/2018UBS GroupUpgradeOutperform ➝ Strong-BuyHigh
1/2/2018Needham & Company LLCBoost Price TargetBuy$85.00 ➝ $88.00Medium
12/26/2017Tigress FinancialReiterated RatingBuyLow
12/5/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ HoldMedium
12/4/2017Raymond JamesReiterated RatingBuyLow
12/4/2017Royal Bank of CanadaSet Price TargetBuy$95.00Low
12/4/2017Robert W. BairdSet Price TargetHold$77.00Medium
12/4/2017Jefferies Financial GroupSet Price TargetHold$76.00Medium
12/4/2017Loop CapitalSet Price TargetHold$73.00Medium
12/4/2017CitigroupSet Price TargetHold$76.00Medium
12/4/2017SVB LeerinkSet Price TargetBuy$85.00High
12/4/2017Needham & Company LLCBoost Price TargetBuy$79.00 ➝ $85.00High
12/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$69.00 ➝ $90.00High
11/10/2017Needham & Company LLCUpgradeHold ➝ Buy$69.02 ➝ $79.00N/A
11/7/2017Loop CapitalLower Price TargetHold$83.00 ➝ $73.00N/A
11/7/2017Jefferies Financial GroupLower Price TargetHold$86.00 ➝ $76.00N/A
11/7/2017SVB LeerinkReiterated RatingHold ➝ Outperform$90.00 ➝ $85.00N/A
11/3/2017CitigroupLower Price TargetNeutral$87.00 ➝ $74.00N/A
10/29/2017CowenSet Price TargetBuy$86.00N/A
10/27/2017Loop CapitalReiterated RatingHoldN/A
10/27/2017Robert W. BairdReiterated RatingHold$77.00N/A
10/24/2017MizuhoSet Price TargetBuy$90.00N/A
10/18/2017Jefferies Financial GroupSet Price TargetHold$86.00N/A
10/12/2017SunTrust BanksSet Price TargetBuy$85.00N/A
10/12/2017Needham & Company LLCReiterated RatingHoldN/A
10/9/2017OppenheimerReiterated RatingBuy$95.00N/A
9/19/2017Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$95.00Low
9/15/2017Jefferies Financial GroupBoost Price TargetHold ➝ Hold$82.00 ➝ $86.00Medium
9/10/2017Needham & Company LLCReiterated RatingHoldLow
8/24/2017Loop CapitalInitiated CoverageHold ➝ Hold$83.00Low
8/17/2017CitigroupLower Price TargetNeutral$88.00 ➝ $87.00Low
8/14/2017Robert W. BairdReiterated RatingOutperform$90.00Low
8/14/2017Wolfe ResearchDowngradeOutperform ➝ Market Perform$89.00 ➝ $82.00Low
(Data available from 8/11/2017 forward)

News Sentiment Rating

0.36 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 49 positive mentions
  • 9 negative mentions
  • 5 very negative mentions
  • 29 very positive mentions
  • 51 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
  • 11 very positive mentions
  • 44 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
  • 13 very positive mentions
  • 38 positive mentions
  • 4 negative mentions
  • 5 very negative mentions
  • 19 very positive mentions
  • 48 positive mentions
  • 5 negative mentions
  • 5 very negative mentions
  • 11 very positive mentions
  • 35 positive mentions
  • 10 negative mentions
  • 3 very negative mentions
  • 13 very positive mentions
  • 28 positive mentions
  • 6 negative mentions
  • 2 very negative mentions
  • 19 very positive mentions
  • 71 positive mentions
  • 8 negative mentions
  • 5 very negative mentions

Current Sentiment

  • 19 very positive mentions
  • 71 positive mentions
  • 8 negative mentions
  • 5 very negative mentions

Recent Stories by Sentiment

CVS Health logo
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Read More

Today's Range

Now: $105.09
Low: $103.79
High: $105.48

50 Day Range

MA: $94.58
Low: $88.66
High: $103.69

52 Week Range

Now: $105.09
Low: $81.78
High: $111.25


86,006 shs

Average Volume

5,143,457 shs

Market Capitalization

$137.97 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?

The following Wall Street analysts have issued stock ratings on CVS Health in the last twelve months: Barclays PLC, BMO Capital Markets, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Edward Jones, JPMorgan Chase & Co., Loop Capital, Mizuho, Morgan Stanley, Raymond James, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Seaport Global Securities, Seaport Res Ptn, Seaport Research Partners, StockNews.com, The Goldman Sachs Group, Inc., Tigress Financial, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for CVS.

What is the current price target for CVS Health?

19 Wall Street analysts have set twelve-month price targets for CVS Health in the last year. Their average twelve-month price target is $117.47, suggesting a possible upside of 12.9%. UBS Group AG has the highest price target set, predicting CVS will reach $127.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $107.00 for CVS Health in the next year.
View the latest price targets for CVS.

What is the current consensus analyst rating for CVS Health?

CVS Health currently has 4 hold ratings and 16 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CVS will outperform the market and that investors should add to their positions of CVS Health.
View the latest ratings for CVS.

What other companies compete with CVS Health?

How do I contact CVS Health's investor relations team?

CVS Health's physical mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator's listed phone number is (401) 765-1500 and its investor relations email address is [email protected] The official website for CVS Health is www.cvshealth.com. Learn More about contacing CVS Health investor relations.